Patents by Inventor Jennifer Elizabeth Golden

Jennifer Elizabeth Golden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES
    Publication number: 20220348558
    Abstract: Compounds of Formula I and Formula II: pharmaceutical compositions containing them, and use of the compounds as active ingredients to treat infection with alphavirus.
    Type: Application
    Filed: September 4, 2020
    Publication date: November 3, 2022
    Inventors: Jennifer Elizabeth Golden, Xufeng Cao, Donghoon Chung, Colleen Beth Jonsson, Xiaoyu Li, Michael Ryan, Jongwoo Son
  • SELECTIVE EFFLUX INHIBITORS AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT
    Publication number: 20160244457
    Abstract: The present invention provides novel compounds which inhibit cancer-associated transporter proteins, methods of treating or preventing the onset of a cancer-associated transporter protein-mediated disease by administering such compounds, and pharmaceutical compositions comprising such compounds. In one embodiment, the invention provides novel pyrazolo[1,5-a]pyrimidine efflux inhibitors that are selective toward ABCG2 over ABCB1.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 25, 2016
    Inventors: Richard Smith Larson, Larry A. Sklar, Bruce S. Edwards, Juan Jacob Strouse, Irena lvnitski-Steele, Hadya M. Khawaja, Jerec Warren Ricci, Jeffrey Aube, Jennifer Elizabeth Golden, TuanIi Yao, Warren S. Weiner, Chad E. Schroeder
  • SELECTIVE EFFLUX INHIBITORS AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT
    Publication number: 20150197526
    Abstract: The present invention provides novel compounds which inhibit cancer-associated transporter proteins, methods of treating or preventing the onset of a cancer-associated transporter protein-mediated disease by administering such compounds, and pharmaceutical compositions comprising such compounds. In one embodiment, the invention provides novel pyrazolo[1,5-a]pyrimidine efflux inhibitors that are selective toward ABCG2 over ABCB1.
    Type: Application
    Filed: December 31, 2014
    Publication date: July 16, 2015
    Inventors: Richard Smith Larson, Larry A. Sklar, Bruce S. Edwards, Juan Jacob Strouse, Irena Ivnitski-Steele, Hydya M. Khawaja, Jerec Warren Ricci, Jeffrey Aube, Jennifer Elizabeth Golden, Tuanli Yao, Warren S. Weiner, Chad E. Schroeder
  • Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment
    Patent number: 9056111
    Abstract: The present invention provides pyrazolo[1,5-a]pyrimidine compounds which inhibit cancer-associated transporter proteins, methods of treating or preventing the onset of a cancer-associated transporter protein-mediated disease by administering such compounds, and pharmaceutical compositions comprising such compounds. In one embodiment, the invention provides pyrazolo[1,5-a]pyrimidine efflux inhibitors that are selective toward ABCG2 over ABCB1. Compounds and compositions according to the present invention may be used to treat cancer, including drug resistant (DR) and multiple drug resistant (MDR) cancers.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: June 16, 2015
    Assignees: STC.UNM, UNIVERSITY OF KANSAS
    Inventors: Richard Smith Larson, Larry A. Sklar, Bruce S. Edwards, Juan Jacob Strouse, Irena Ivnitski-Steele, Hadya M. Khawaja, Jerec Warren Ricci, Jeffrey Aube, Jennifer Elizabeth Golden, Tuanli Yao, Warren S. Weiner, Chad E. Schroeder